Larson Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.3K | Buy |
1,091
+233
| +27% | +$3.91K | ﹤0.01% | 1522 |
|
|
2025
Q1 | $13.2K | Buy |
858
+29
| +3% | +$446 | ﹤0.01% | 1521 |
|
|
2024
Q4 | $18.3K | Buy |
829
+150
| +22% | +$3.31K | ﹤0.01% | 1249 |
|
|
2024
Q3 | $12.2K | Hold |
679
| – | – | ﹤0.01% | 1387 |
|
|
2024
Q2 | $11K | Hold |
679
| – | – | ﹤0.01% | 1230 |
|
|
2024
Q1 | $9.58K | Hold |
679
| – | – | ﹤0.01% | 1051 |
|
|
2023
Q4 | $7.09K | Hold |
679
| – | – | ﹤0.01% | 1101 |
|
|
2023
Q3 | $6.93K | Buy |
679
+87
| +15% | +$887 | ﹤0.01% | 1094 |
|
|
2023
Q2 | $4.46K | Hold |
592
| – | – | ﹤0.01% | 1125 |
|
|
2023
Q1 | $5.24K | Buy |
592
+217
| +58% | +$1.92K | ﹤0.01% | 1076 |
|
|
2022
Q4 | $3.42K | Hold |
375
| – | – | ﹤0.01% | 1106 |
|
|
2022
Q3 | $3K | Hold |
375
| – | – | ﹤0.01% | 1073 |
|
|
2022
Q2 | $3K | Hold |
375
| – | – | ﹤0.01% | 986 |
|
|
2022
Q1 | $4K | Hold |
375
| – | – | ﹤0.01% | 840 |
|
|
2021
Q4 | $3K | Hold |
375
| – | – | ﹤0.01% | 915 |
|
|
2021
Q3 | $4K | Hold |
375
| – | – | ﹤0.01% | 727 |
|
|
2021
Q2 | $4K | Hold |
375
| – | – | ﹤0.01% | 661 |
|
|
2021
Q1 | $4K | Hold |
375
| – | – | ﹤0.01% | 654 |
|
|
2020
Q4 | $4K | Hold |
375
| – | – | ﹤0.01% | 586 |
|
|
2020
Q3 | $3K | Hold |
375
| – | – | ﹤0.01% | 569 |
|
|
2020
Q2 | $5K | Hold |
375
| – | – | ﹤0.01% | 489 |
|
|
2020
Q1 | $3K | Buy |
+375
| New | +$3K | ﹤0.01% | 412 |
|